ESC 365 - Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Open Access

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Session: Latest registries and observational studies

Topic: Pharmacotherapy

Speaker: Doctor K. Berge (Nordbyhagen, NO)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Kristian Berge

Akershus University Hospital - AHUS, Nordbyhagen (Norway)

1 presentation

0 follower

6 more presentations in this session

Discussant panel

Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence

Speaker: Doctor F. Lindberg (Stockholm, SE)

Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

Speaker: Doctor R. Inciardi (Brescia, IT)

Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

Speaker: Doctor A. Villaschi (Stockholm, SE)

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Speaker: Doctor C. Basile (Stockholm, SE)

Access the full session

Latest registries and observational studies

Speakers: Doctor K. Berge, Doctor F. Lindberg, Doctor R. Inciardi, Doctor A. Villaschi, Doctor C. Basile

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources